Suicidal brain cells can be saved

Knight, Jonathan
May 1998
New Scientist;05/09/98, Vol. 158 Issue 2133, p21
Reports that a way has been found to reduce the damage to brain cells temporarily deprived of oxygen. Discovery that brain cells do not die as soon as they are deprived of oxygen; Length of time that cells can survive without oxygen; Description of apoptosis, or cell suicide; Enzymes called caspases that are released by the cell during apoptosis; Blocking of caspases by a substance called BAF; Research published in `Journal of Clinical Investigation.'


Related Articles

  • An attack on aging. Gorman, Christine // Time International (South Pacific Edition);01/26/98, Issue 4, p53 

    Points out how scientists have discovered how an enzyme called telomerase can revive dying cells. The experiment, which is sponsored by the US National Institute on Aging and the Geron biotech company of Menlo Park, California, as appearing in the journal `Science'; The evidence that each of...

  • Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase. Jee-Yin Ahn; Xia Liu; Zhixue Liu; Pereira, Lorena; Dongmei Cheng; Junmin Peng; Wade, Paul A.; Hamburger, Anne W.; Keqiang Ye // EMBO Journal;5/17/2006, Vol. 25 Issue 10, p2083 

    Akt promotes cell survival through phosphorylation. The physiological functions of cytoplasmic Akt have been well defined, but little is known about the nuclear counterpart. Employing a cell-free apoptotic assay and NGF-treated PC12 nuclear extracts, we purified Ebp1 as a factor, which...

  • Death deceiver. Green, Douglas R. // Nature;12/17/1998, Vol. 396 Issue 6712, p629 

    Discusses a report by R.M. Pitti of a newly discovered mechanism that tumors use to avoid a death signal. Details about the production of a soluble molecule which binds to, and neutralizes, a trigger for apoptosis; Possibilities to explain how Fas ligand (FasL) restricts tumor growth.

  • From bench to clinic with apoptosis-based therapeutic agents. Nicholson, Donald W. // Nature;10/12/2000, Vol. 407 Issue 6805, p810 

    Discusses the possible therapeutic aspects of apoptosis, or programed cell death. How apoptosis almost always plays a part in the basis of human disease pathogenesis; Increased research in apoptosic therapeutics as of October, 2000; How the ability to modulate the life or death of a cell to...

  • PGRMC1 Enables P4 to Prevent Apoptosis.  // Fertility Weekly;10/12/2009, p5 

    The article reports on the result of the study led by J. J. Peluso to determine whether progesterone receptor membrane component-1 (PGRMC1) meditate the actions of P4 thus, preventing apoptosis. The study includes Granulosa/Luteal (GL) cells from women undergoing ovulation induction. Result of...

  • Increased HoxB4 Inhibits Apoptotic Cell Death in Pro-B Cells. Sung-Won Park; Kyung-Jong Won; Yong-Soo Lee; Hye Sun Kim; Yu-Kyung Kim; Hyeon-Woo Lee; Bokyung Kim; Byeong Han Lee; Jin-Hoi Kim; Dong-Ku Kim // Korean Journal of Physiology & Pharmacology;Aug2012, Vol. 16 Issue 4, p265 

    HoxB4, a homeodomain-containing transcription factor, is involved in the expansion of hematopoietic stem cells and progenitor cells in vivo and in vitro, and plays a key role in regulating the balance between hematopoietic stem cell renewal and cell differentiation. However, the biological...

  • Ototoxicity from Combined Cisplatin and Radiation Treatment: An In Vitro Study. Low, Wong-Kein; Kong, Sylvia W. W.; Tan, Michelle G. K. // International Journal of Otolaryngology;2010, p1 

    Objective. Combined cisplatin (CDDP) and radiotherapy is increasingly being used to treat advanced head and neck cancers. As both CDDP and radiation can cause hearing loss, it is important to have a better understanding of the cellular and molecular ototoxic mechanisms involved in combined...

  • Killing a cancer: what are the alternatives? Kreuzaler, Peter; Watson, Christine J. // Nature Reviews Cancer;Jun2012, Vol. 12 Issue 6, p411 

    Evading programmed cell death is one of the hallmarks of cancer. Conversely, inducing cell death by pharmacological means is the basis of almost every non-invasive cancer therapy. Research over the past decade has greatly increased our understanding of non-apoptotic programmed cell death events,...

  • Preliminary safety evaluation of novel small molecule inhibitors of caspase-3. Samiulla, D. S.; Naidu, A.; Ramachandra, M. // Journal of Chemical & Pharmaceutical Research;2012, Vol. 4 Issue 6, p3129 

    Caspase inhibition was known to be therapeutically effective in treating the excessive programmed cell death related disorders. We investigated the novel, potent and irreversible small molecules inhibitors of caspase-3 having reasonable selectivity, ADME properties and pharmacologically active...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics